Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Saracco

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|April 1, 2017
Finally, it is bismuth's timeDavide G Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Anais Brasileiros De Dermatologia|September 28, 2017
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasisDavide Giuseppe Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Gastroenterology Research and Practice|September 20, 2016
Response to: Comment on "Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients"Davide Giuseppe Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Balkan Medical Journal|June 1, 2017
Amoxycillin and Metronidazole Therapy for Helicobacter pylori Eradication: A 10-Year Trend in Turin, ItalyDavide Giuseppe Ribaldone, Marco Astegiano, Giorgio Saracco, et al.
Helicobacter|August 29, 2009
Helicobacters and extragastric diseasesRinaldo Pellicano, Francesco Franceschi, Giorgio Saracco, et al.
European Journal of Gastroenterology & Hepatology|May 7, 2011
Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertensionChiara Elia, Wilma Debernardi Venon, Davide Stradella, et al.
Digestive Diseases and Sciences|May 14, 2004
Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infectionRinaldo Pellicano, Giovanni Antonio Touscoz, Antonina Smedile, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?Vito Di Marco, Roberta D'Ambrosio, Fabrizio Bronte, et al.
Digestive Diseases and Sciences|February 22, 2002
Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertensionWilma Debernardi-Venon, Claudio Barletti, Carlo Alessandria, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|April 1, 2017
Finally, it is bismuth's timeDavide G Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Anais Brasileiros De Dermatologia|September 28, 2017
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasisDavide Giuseppe Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Gastroenterology Research and Practice|September 20, 2016
Response to: Comment on "Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients"Davide Giuseppe Ribaldone, Giorgio Saracco, Rinaldo Pellicano
Balkan Medical Journal|June 1, 2017
Amoxycillin and Metronidazole Therapy for Helicobacter pylori Eradication: A 10-Year Trend in Turin, ItalyDavide Giuseppe Ribaldone, Marco Astegiano, Giorgio Saracco, et al.
Helicobacter|August 29, 2009
Helicobacters and extragastric diseasesRinaldo Pellicano, Francesco Franceschi, Giorgio Saracco, et al.
European Journal of Gastroenterology & Hepatology|May 7, 2011
Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertensionChiara Elia, Wilma Debernardi Venon, Davide Stradella, et al.
Digestive Diseases and Sciences|May 14, 2004
Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infectionRinaldo Pellicano, Giovanni Antonio Touscoz, Antonina Smedile, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?Vito Di Marco, Roberta D'Ambrosio, Fabrizio Bronte, et al.
Digestive Diseases and Sciences|February 22, 2002
Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertensionWilma Debernardi-Venon, Claudio Barletti, Carlo Alessandria, et al.
Pageof 4